Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-04

Clinical Trial Update: Automated Adjustment of Oxygen on Patient With Acute COPD Exacerbation - FreeO2 HypHop [NA]

View source ↗

Summary

A terminated clinical trial update on the automated oxygen adjustment system FreeO2 HypHop used in patients with acute COPD exacerbation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FreeO2 HypHop

Snippet

Sponsor: Laval University | Conditions: Oxygen Toxicity, COPD Exacerbation | NA | Status: TERMINATED